{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:31:49Z","timestamp":1773984709757,"version":"3.50.1"},"reference-count":23,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"\n Background & objectives:<\/jats:title>\n Antimicrobial resistance is a major challenge in the treatment of typhoid fever with limited choices left to empirically treat these patients. The present study was undertaken to determine the current practices of antibiotic use in children attending a tertiary care hospital in north India.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n This was a descriptive observational study in children suffering from enteric fever as per the case definition including clinical and laboratory parameters. The antibiotic audit in hospitalized children was measured as days of therapy per 1000 patient days and in outpatient department (OPD) as antibiotic prescription on the treatment card.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A total of 128 children with enteric fever were included in the study, of whom, 30 were hospitalized and 98 were treated from OPD. The mean duration of fever was 9.5 days at the time of presentation. Of these, 45 per cent were culture positive with Salmonella<\/jats:italic> Typhi being aetiological agent in 68 per cent followed by S. Paratyphi A in 32 per cent. During hospitalization, the average length of stay was 10 days with mean duration of defervescence 6.4 days. Based on antimicrobial susceptibility ceftriaxone was given to 28 patients with mean duration of treatment being six days. An additional antibiotic was needed in six patients due to clinical non-response. In OPD, 79 patients were prescribed cefixime and additional antibiotic was needed in five during follow up visit.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Based on our findings, ceftriaxone and cefixime seemed to be the first line of antibiotic treatment for typhoid fever. Despite susceptibility, clinical non-response was seen in around 10 per cent of the patients who needed combinations of antibiotics.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_199_18","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T07:30:52Z","timestamp":1559547052000},"page":"263-269","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Current antibiotic use in the treatment of enteric fever in children"],"prefix":"10.25259","volume":"149","author":[{"given":"Sushila","family":"Dahiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rooma","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil Kumar","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamini","family":"Walia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.C.","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-21-20241212","doi-asserted-by":"crossref","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: Systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"R2-21-20241212","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"R3-21-20241212","doi-asserted-by":"crossref","first-page":"e2925","DOI":"10.1371\/journal.pntd.0002925","article-title":"Estimating the burden of paratyphoid a in Asia and Africa","volume":"8","author":"Arndt","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"R4-21-20241212","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"R5-21-20241212","first-page":"179","article-title":"S. typhi with transferable chloramphenicol resistance isolated in Chandigarh during 1983-87","volume":"37","author":"Kapil","year":"1994","journal-title":"Indian J Pathol Microbiol"},{"key":"R6-21-20241212","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2015.03.102","article-title":"Antimicrobial resistance and management of invasive Salmonella disease","volume":"33","author":"Kariuki","year":"2015","journal-title":"Vaccine"},{"key":"R7-21-20241212","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/emi.2016.62","article-title":"The emergence and outbreak of multidrug-resistant typhoid fever in China","volume":"5","author":"Yan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"R8-21-20241212","doi-asserted-by":"crossref","first-page":"e14003","DOI":"10.7554\/eLife.14003","article-title":"A novel ciprofloxacin-resistant subclade of H58 Salmonella typhi is associated with fluoroquinolone treatment failure","volume":"5","author":"Pham Thanh","year":"2016","journal-title":"Elife"},{"key":"R9-21-20241212","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QCO.0b013e32830f453a","article-title":"Antimicrobial resistance in typhoidal and nontyphoidal Salmonellae","volume":"21","author":"Parry","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R10-21-20241212","first-page":"746","article-title":"Induction of resistant mutants of Salmonella enterica serotype typhi under ciprofloxacin selective pressure","volume":"139","author":"Dahiya","year":"2014","journal-title":"Indian J Med Res"},{"key":"R11-21-20241212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/1076629041310028","article-title":"Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype typhi and serotype paratyphi A","volume":"10","author":"Renuka","year":"2004","journal-title":"Microb Drug Resist"},{"key":"R12-21-20241212","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1099\/jmm.0.45966-0","article-title":"High-level ciprofloxacin resistance in Salmonella enterica serotype typhi in India","volume":"54","author":"Renuka","year":"2005","journal-title":"J Med Microbiol"},{"key":"R13-21-20241212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/ijmm.IJMM_16_382","article-title":"Characterisation of antimicrobial resistance in Salmonellae during 2014-2015 from four centres across India: An ICMR antimicrobial resistance surveillance network report","volume":"35","author":"Dahiya","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"R14-21-20241212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijmm.IJMM_17_412","article-title":"Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian hospital over the last decade","volume":"36","author":"Sharma","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"R16-21-20241212","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3201\/eid2004.131536","article-title":"Salmonella subtypes with increased MICs for azithromycin in travelers returned to the Netherlands","volume":"20","author":"Hassing","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R17-21-20241212","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-21-20241212","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.333.7558.78","article-title":"Current concepts in the diagnosis and treatment of typhoid fever","volume":"333","author":"Bhutta","year":"2006","journal-title":"BMJ"},{"key":"R19-21-20241212","doi-asserted-by":"crossref","first-page":"e0006380","DOI":"10.1371\/journal.pntd.0006380","article-title":"Open label comparative trial of mono versus dual antibiotic therapy for typhoid fever in adults","volume":"12","author":"Zmora","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"R21-21-20241212","first-page":"884","article-title":"IAP Task Force Report: Management of enteric fever in children","volume":"43","author":"Kundu","year":"2006","journal-title":"Indian Pediatr"},{"key":"R29-21-20241212","first-page":"35","article-title":"Comparison of Widal test with immunochromatography and enzyme immuno assay for Salmonella typhi IgM and IgG Antibodies","volume":"2","author":"Danu","year":"2013","journal-title":"Res Rev J Microbiol Biotech"},{"key":"R30-21-20241212","first-page":"196","article-title":"Usefulness of defined daily dose and days of therapy in pediatrics and obstetrics-gynecology: A comparative analysis of antifungal drugs (2000-2001, 2005-2006, and 2010-2011)","volume":"19","author":"Guillot","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R32-21-20241212","first-page":"77","article-title":"API recommendations for the management of typhoid fever","volume":"63","author":"Upadhyay","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"R33-21-20241212","doi-asserted-by":"crossref","first-page":"FSO312","DOI":"10.4155\/fsoa-2018-0003","article-title":"Typhoid fever: Issues in laboratory detection, treatment options & concerns in management in developing countries","volume":"4","author":"Veeraraghavan","year":"2018","journal-title":"Future Sci OA"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949020-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:01:15Z","timestamp":1751497275000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/current-antibiotic-use-in-the-treatment-of-enteric-fever-in-children\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_199_18","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}